<DOC>
	<DOC>NCT02471781</DOC>
	<brief_summary>The Zenith TX2 Low Profile TAA Endovascular Graft extended study is to collect confirmatory safety and effectiveness data. The Zenith TX2 Low Profile TAA Endovascular Graft is indicated for the treatment of patients with a descending thoracic aortic aneurysm or penetrating ulcer and has an anatomy suitable for repair.</brief_summary>
	<brief_title>Zenith® TX2® Low Profile TAA Endovascular Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<criteria>Meets one of the following Descending thoracic aneurysm with diameter ≥ 5.0 cm Descending thoracic aneurysm with a history of growth ≥ 0.5 cm per year Descending thoracic degenerative or atherosclerotic ulcer ≥ 10 mm in depth and 20 mm in diameter Life expectancy less than 2 years Pregnant of breastfeeding or planning on becoming pregnant within 60 months Unwilling to comply with the followup schedule Less than 30 days beyond primary endpoint for other investigative drug or device study Receiving home oxygen Myocardial infarction within the last 3 months Stroke within the last 3 months Diagnosed or suspected congenital degenerative collagen disease Systemic infection Bleeding diathesis, uncorrectable coagulopathy, or refuses blood transfusion Allergy to polyester, polypropylene, nitinol, or gold Previous placement of a thoracic endovascular graft Prior open repair involving the descending thoracic aorta</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Aortic Aneurysm</keyword>
	<keyword>Aneurysm</keyword>
	<keyword>Vascular Prosthesis</keyword>
	<keyword>Vascular Disease</keyword>
	<keyword>Blood Vessel Prosthesis Implantation</keyword>
</DOC>